{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:36:50Z","timestamp":1781566610960,"version":"3.54.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000008191","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T16:21:01Z","timestamp":1506529261000},"page":"e8191","source":"Crossref","is-referenced-by-count":6,"title":["Neuroleptic malignant syndrome with thyroid disorder"],"prefix":"10.1097","volume":"96","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Kanzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Paras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-72-20210309","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJM198507183130306","article-title":"Current concepts. Neuroleptic malignant syndrome","volume":"313","author":"Guze","year":"1985","journal-title":"N Engl J Med"},{"key":"R2-72-20210309","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.53.6.517","article-title":"Neuroleptic malignant syndrome and hypothyroidism","volume":"53","author":"Moore","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R3-72-20210309","first-page":"VD01","article-title":"A rare case of myxedema coma with neuroleptic malignant syndrome (NMS)","volume":"9","author":"Dixit","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"R4-72-20210309","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-199819010-00006","article-title":"Neuroleptic malignant syndrome. Recognition, prevention and management","volume":"19","author":"Velamoor","year":"1998","journal-title":"Drug Saf"},{"key":"R5-72-20210309","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"key":"R6-72-20210309","first-page":"18","article-title":"Mortality from neuroleptic malignant syndrome","volume":"50","author":"Shalev","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"R7-72-20210309","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1176\/appi.psy.50.1.8","article-title":"Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature","volume":"50","author":"Seitz","year":"2009","journal-title":"Psychosomatics"},{"key":"R8-72-20210309","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin North Am"},{"key":"R9-72-20210309","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/hup.483","article-title":"Olanzapine induced neuroleptic malignant syndrome\u2014a case review","volume":"18","author":"Kogoj","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"R10-72-20210309","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1176\/ajp.146.6.717","article-title":"A prospective analysis of 24 episodes of neuroleptic malignant syndrome","volume":"146","author":"Rosebush","year":"1989","journal-title":"Am J Psychiatry"},{"key":"R11-72-20210309","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/mds.20689","article-title":"Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal","volume":"20","author":"Thomas","year":"2005","journal-title":"Mov Disord"},{"key":"R12-72-20210309","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8627(05)70127-9","article-title":"The neuroleptic malignant and serotonin syndromes","volume":"18","author":"Carbone","year":"2000","journal-title":"Emerg Med Clin North Am"},{"key":"R13-72-20210309","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00004714-200206000-00004","article-title":"High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome","volume":"22","author":"Hermesh","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"R14-72-20210309","first-page":"136","article-title":"[A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam]","volume":"42","author":"Kawajiri","year":"2002","journal-title":"Rinsho Shinkeigaku"},{"key":"R15-72-20210309","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1592\/phco.21.11.1003.34528","article-title":"Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics","volume":"21","author":"Hatch","year":"2001","journal-title":"Pharmacotherapy"},{"key":"R16-72-20210309","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.pnpbp.2005.04.004","article-title":"Possible malignant neuroleptic syndrome that associated with hypothyroidism","volume":"29","author":"Taskapan","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R17-72-20210309","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1345\/aph.1M369","article-title":"Myxedema coma associated with combination aripiprazole and sertraline therapy","volume":"43","author":"Church","year":"2009","journal-title":"Ann Pharmacother"},{"key":"R18-72-20210309","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/WNF.0b013e31823429a7","article-title":"Thyroid adverse effects of psychotropic drugs: a review","volume":"34","author":"Bou Khalil","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"R19-72-20210309","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/taap.1998.8367","article-title":"Relationship between psychotropic drugs and thyroid function: a review","volume":"149","author":"Sauvage","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"R20-72-20210309","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3565(25)26418-7","article-title":"The effect of acute and chronic administration of chlorpromazine on the I-131 distribution in normal rats","volume":"138","author":"Wiseman","year":"1962","journal-title":"J Pharmacol Exp Ther"},{"key":"R21-72-20210309","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0022-3565(25)11670-4","article-title":"The direct antithyroid action of reserpine, chlorpromazine and other drugs","volume":"117","author":"Mayer","year":"1956","journal-title":"J Pharmacol Exp Ther"},{"key":"R22-72-20210309","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1563-2571.2000.00102.x","article-title":"Interaction between psychotropic drugs and thyroid hormone metabolism\u2014an overview","volume":"27","author":"Ramschak-Schwarzer","year":"2000","journal-title":"Acta Med Austriaca"},{"key":"R23-72-20210309","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4088\/JCP.10m06438","article-title":"An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method","volume":"72","author":"Gurrera","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"R24-72-20210309","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JCP.0000000000000640","article-title":"A validation study of the international consensus diagnostic criteria for neuroleptic malignant syndrome","volume":"37","author":"Gurrera","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"R25-72-20210309","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1086\/317521","article-title":"Role of the preoptic-anterior hypothalamus in thermoregulation and fever","volume":"31","author":"Boulant","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R26-72-20210309","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.31.2.132","article-title":"Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?","volume":"31","author":"Henderson","year":"1981","journal-title":"Neurology"},{"key":"R27-72-20210309","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/bja\/85.1.129","article-title":"Neuroleptic malignant syndrome","volume":"85","author":"Adnet","year":"2000","journal-title":"Br J Anaesth"},{"key":"R28-72-20210309","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002826-200207000-00001","article-title":"Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?","volume":"25","author":"Gurrera","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"R29-72-20210309","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0196-9781(87)90107-0","article-title":"Modulation of dopamine receptors by thyrotropin-releasing hormone in the rat brain","volume":"8","author":"Funatsu","year":"1987","journal-title":"Peptides"},{"key":"R30-72-20210309","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000124797","article-title":"The secretory activity of the tuberoinfundibular dopaminergic neurons is modulated by the thyroid status in the adult rat: consequence on prolactin secretion","volume":"46","author":"Reymond","year":"1987","journal-title":"Neuroendocrinology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T22:38:31Z","timestamp":1750891111000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709290-00072"}},"subtitle":["An unusual case report"],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008191","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}